You are here

Show:
Printer-friendly versionPrinter-friendly version
  • Zarin D, Tse T. Trust but verify: trial registration and determining fidelity to the protocol [Letter]. Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011.
  • Zarin D, Tse T. Clarification about ClinicalTrials.gov [Letter]. IRB. 2013 May-Jun;35(3):19.
  • Zarin D, Tse T. The effect of funding source on outcome reporting among drug trials [Letter]. Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020.
  • Zarin DA, Williams RJ, Bergeris AM, Dobbins H, Ide NC, Loane RF, Robbins A, Tse T. ClinicalTrials.gov and Related Projects: Improving Access to Information about Clinical Trials April 2013 Technical Report to the LHNCBC Board of Scientific Counselors
  • Zarin DA, Tse T. Unambiguous identification of obesity trials [Letter]. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.
  • Zeng K, Bodenreider O. Experience in Integrating Large RDF-based Biomedical Knowledge Resources with Oracle [Abstract]. Proc 8th International Oracle Life Sciences User Group Meeting 2007:(electronic proceedings: http://www.olsug.org/wiki/images/d/d1/Kelly_Zheng.pdf)

Pages